[Skip to Content]
[Skip to Content Landing]
Views 201
Citations 0
Editor's Note
August 14, 2019

Risk Prediction Model in Children With Hypertrophic Cardiomyopathy: A Work in Progress

Author Affiliations
  • 1Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 2Editor, JAMA Cardiology
  • 3Center for Genetic Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois
  • 4Associate Editor, JAMA Cardiology
JAMA Cardiol. Published online August 14, 2019. doi:10.1001/jamacardio.2019.2945

Managing sudden death risk in young patients with hypertrophic cardiomyopathy (HCM) is challenging for its lifetime implications from both action and inaction, and this decision often relies on shared decision-making by families and clinicians. Thus, the development of risk assessment tools to guide parents and health care professionals are welcome additions to the scientific literature. The study by Norrish and coworkers1 in this issue of JAMA Cardiology is an initial step in creating a risk tool, and as a first step, the editors hope this work will stimulate further discussion and investigation to better refine this tool.